Akebia Therapeutics

AKBA

Market cap $324M

Buy

Hold

Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

Avg. target

$4.67

283% upside

High target

positive

0 neutral

negative

Analyst & Firm	Rating	Price Target	Upside Downside	Date
BTIG Julian Harrison 0% 1-yr AKBA win rate				25 Feb ‘26 6 days ago
Piper Sandler Allison Bratzel 0% 1-yr AKBA win rate				6 Feb ‘26 25 days ago
HC Wainwright & Co Matthew Caufield 0% 1-yr AKBA win rate				6 Feb ‘26 25 days ago